Gershaw v. THER-A-PEDIC SLEEP PROD., INC.
This text of 527 A.2d 923 (Gershaw v. THER-A-PEDIC SLEEP PROD., INC.) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
GERALD GERSHAW, PLAINTIFF-APPELLANT,
v.
THER-A-PEDIC SLEEP PRODUCTS, INC.; HAROLD WINIKOFF; BENJAMIN WINIKOFF; RICHARD WINIKOFF AND GARY GERSHAW, DEFENDANTS-RESPONDENTS.
Superior Court of New Jersey, Appellate Division.
*353 Before Judges GAULKIN, BAIME and ASHBEY.
John P. Palmisano argued the cause for appellant (Andora, Palmisano, Harris & Romano, attorneys; Marchi, Jaffe, Cohen, Crystal, Rosner & Katz, Special Counsel; Ernest Allen Cohen, John P. Palmisano and Jonathan N. Harris, on the brief).
Stephen N. Dratch argued the cause for respondents Ther-A-Pedic Sleep Products, Inc. and Gary Gershaw (Greenberg, Margolis, Ziegler, Schwartz, Dratch, Fishman, Franzblau & Falkin, P.A., attorneys; Martin L. Greenberg, of counsel).
Donohue & Hughes, attorneys for respondents Harold Winikoff, Benjamin Winikoff and Richard Winikoff (Richard J. Donohue, of counsel).
The opinion of the court was delivered by GAULKIN, J.A.D.
Plaintiff Gerald Gershaw (Gershaw) brought this action as a stockholder of defendant Ther-A-Pedic Sleep Products, Inc. (Ther-A-Pedic). His complaint, filed November 15, 1984, asserted a variety of derivative claims on behalf of Ther-A-Pedic against the individual defendants as officers and directors, demanded permission to inspect the corporate records and sought declaratory judgment that Gershaw and other named persons had been duly elected as directors at a September 6, 1984 shareholder's meeting. The parties immediately set into what became a protracted and bitter litigation. Crossclaims, counterclaims, third-party complaints were filed; additional parties were brought in; motions and cross-motions proliferated. The proceedings culminated in a final hearing at which but one witness testified. On August 5, 1986, the trial judge entered judgment, among other things, (1) denying all relief to Gershaw; *354 (2) declaring that Gershaw owns 25% of the Ther-A-Pedic stock; (3) fixing the value of all of the Ther-A-Pedic stock at $1,200,000 and (4) incorporating, by implication, a February 18, 1986 order which authorized the individual defendants to purchase Gershaw's stock. Gershaw appeals.
I.
Gershaw's central contention is that the trial judge was without authority to mandate that he sell his shares to the individual defendants. The order granting that relief recites that it is entered "pursuant to N.J.S.A. 14A:12-7(8)," which provides:
Upon motion of the corporation or a holder or holders of 50 percent or more of the outstanding voting shares of the corporation, before or after the appointment of a custodian or provisional director, the court may order the sale by the plaintiff or plaintiffs of all shares of the corporation's stock held by them to either the corporation or the moving shareholders, whichever is specified in the motion, if the court determines in its discretion that such an order would be fair and equitable to all parties under all of the circumstances of the case.
The court can order a stock sale under that section, however, only in an action "brought under" N.J.S.A. 14A:12-7(1):
The Superior Court, in an action brought under this section, may appoint a custodian, appoint a provisional director, order a sale of the corporation's stock as provided below, or enter a judgment dissolving the corporation, upon proof that
(a) the shareholders of the corporation are so divided in voting power that, for a period which includes the time when two consecutive annual meetings were or should have been held, they have failed to elect successors to directors whose terms have expired or would have expired upon the election and qualification of their successors; or
(b) the directors of the corporation, or the person or persons having the management authority otherwise in the board, if a provision in the corporation's certificate of incorporation contemplated by subsection 14A:5-21(2) is in effect, are unable to effect action on one or more substantial matters respecting the management of the corporation's affairs; or
(c) in the case of a corporation having 25 or less shareholders, the directors or those in control have acted fraudulently or illegally, mismanaged the corporation, or abused their authority as officers or directors or have acted oppressively or unfairly towards one or more minority shareholders in their capacities as shareholders, directors, officers, or employees.
*355 We are satisfied that Gershaw's action was not "brought under" N.J.S.A. 14A:12-7(1) and thus the court had no authority to order the sale of Gershaw's stock under N.J.S.A. 14A:12-7(8).
N.J.S.A. 14A:12-7(1) appears in Chapter 12 of Title 14A, entitled "Dissolution." Its predecessor provided for involuntary dissolution upon a showing of corporate deadlock and an inability "to function normally in the best interests of its creditors and shareholders." The Commissioners' Comment to the 1972 amendment (L. 1973, c. 366, § 67, effective May 1, 1974) noted that the section has been "substantially revised to enlarge the grounds on which an action may be brought and to provide additional remedies." The reason for the changes was described as follows:
The Commission was mindful on the one hand that the principals of a business enterprise, even if profitable, should not be joined irrevocably together if there is substantial dissension among them and, on the other, that dissolution of a business is a drastic remedy to be applied with caution. In addition, the Commission recognized that there is often a public interest involved in avoiding dissolution as a remedy in the event of deadlock or internal dissension.
The design of N.J.S.A. 14A:12-7(1) is thus to provide for involuntary dissolution or, where appropriate, less drastic alternative remedies. Gershaw did not seek to dissolve the corporation nor did he seek relief as an alternative to dissolution; indeed he did not ask the court to intervene at all in the corporate structure or governance. His derivative claims were brought on behalf of the corporation and were subject to N.J.S.A. 14A:3-6. His demand for inspection of corporate records was a personal claim asserted under N.J.S.A. 14A:5-28 and his demand for declaratory judgment (N.J.S.A. 2A:16-50 et seq.) simply sought a determination as to the membership of the board of directors. Nothing in the language or history of N.J.S.A. 14A:12-7(1) suggests that the assertion of such claims can justify the forced sale of the claimant's stock. To treat such claims as being "brought under" the statute would put every minority stockholder in peril of involuntary sale upon the making of any claim at all.
*356 The relief of forced sale under N.J.S.A. 14A:12-7(8) is available to buy out "the plaintiff or plaintiffs" who seek dissolution of the corporation; as an alternative and less drastic form of relief, and upon motion of the corporation or a holder or holders of 50% or more of the outstanding voting shares, "the plaintiff or plaintiffs" can be ordered to sell their stock. Here Gershaw was not such a "plaintiff" and defendants, even if they were properly deemed to hold more than 50% of the outstanding voting stock, had no right to relief under the statute.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
527 A.2d 923, 218 N.J. Super. 350, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gershaw-v-ther-a-pedic-sleep-prod-inc-njsuperctappdiv-1987.